Drugs / carbendazim

Trials 2

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00003709 Oct 1998 → Nov 2000 cancer of unknown primary site The University of Texas Health Science Center at San Antonio Completed No outcome recorded
Phase 1 NCT00023816 — cancer of unknown primary site, lymphoma Jonsson Comprehensive Cancer Center Unknown No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as carbendazim ClinicalTrials.gov intervention name — accepted as the source's own label NCT00023816 ↗
1

NCT00003709 ↗

Known as A 118 ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as BAS-67054F ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as Bavistin ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as Derroprene ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as EK-578 ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as FB-642 ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as Fenbendazole related compound a ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as Lignasan ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as NSC-109874 ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Known as Thicoper ChEMBL registry synonym — accepted as the source's own label CHEMBL70971 ↗
Modality Small molecule — CHEMBL70971 ↗
Route Oral “Patients receive oral carbendazim weekly for 3 weeks” NCT00003709 ↗